| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 71335-1214-3 | 71335-1214 | HUMAN PRESCRIPTION DRUG | BUPROPION HYDROCHLORIDE | BUPROPION HYDROCHLORIDE | TABLET, EXTENDED RELEASE | ORAL | 20190610 | N/A | ANDA | ANDA210497 | Bryant Ranch Prepack | BUPROPION HYDROCHLORIDE | 300 mg/1 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1214-3) |
| 71335-1214-4 | 71335-1214 | HUMAN PRESCRIPTION DRUG | BUPROPION HYDROCHLORIDE | BUPROPION HYDROCHLORIDE | TABLET, EXTENDED RELEASE | ORAL | 20190529 | N/A | ANDA | ANDA210497 | Bryant Ranch Prepack | BUPROPION HYDROCHLORIDE | 300 mg/1 | 120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1214-4) |
| 71335-1214-5 | 71335-1214 | HUMAN PRESCRIPTION DRUG | BUPROPION HYDROCHLORIDE | BUPROPION HYDROCHLORIDE | TABLET, EXTENDED RELEASE | ORAL | 20240809 | N/A | ANDA | ANDA210497 | Bryant Ranch Prepack | BUPROPION HYDROCHLORIDE | 300 mg/1 | 8 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1214-5) |
| 71335-1214-6 | 71335-1214 | HUMAN PRESCRIPTION DRUG | BUPROPION HYDROCHLORIDE | BUPROPION HYDROCHLORIDE | TABLET, EXTENDED RELEASE | ORAL | 20240809 | N/A | ANDA | ANDA210497 | Bryant Ranch Prepack | BUPROPION HYDROCHLORIDE | 300 mg/1 | 180 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1214-6) |